SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $18,000 | -45.5% | 190 | -55.0% | 0.00% | -42.9% |
| Q2 2021 | $33,000 | +17.9% | 422 | +10.5% | 0.01% | +16.7% |
| Q1 2021 | $28,000 | -22.2% | 382 | +78.5% | 0.01% | -25.0% |
| Q4 2020 | $36,000 | +9.1% | 214 | -9.3% | 0.01% | -11.1% |
| Q3 2020 | $33,000 | -2.9% | 236 | +9.8% | 0.01% | -18.2% |
| Q2 2020 | $34,000 | +41.7% | 215 | -13.0% | 0.01% | +10.0% |
| Q1 2020 | $24,000 | -7.7% | 247 | +24.1% | 0.01% | +42.9% |
| Q4 2019 | $26,000 | +2500.0% | 199 | +1143.8% | 0.01% | – |
| Q3 2019 | $1,000 | -96.0% | 16 | -90.2% | 0.00% | -100.0% |
| Q2 2019 | $25,000 | – | 164 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 112,689 | $14,541,000 | 14.93% |
| Casdin Capital, LLC | 670,000 | $86,457,000 | 7.95% |
| Logos Global Management LP | 226,002 | $29,163,000 | 7.19% |
| Avoro Capital Advisors LLC | 1,760,000 | $227,110,000 | 6.67% |
| Camber Capital Management LP | 600,000 | $77,424,000 | 3.94% |
| STANSBERRY ASSET MANAGEMENT, LLC | 71,133 | $9,179,000 | 3.74% |
| Eventide Asset Management | 996,000 | $128,524,000 | 3.62% |
| CADIAN CAPITAL MANAGEMENT, LP | 550,000 | $70,972,000 | 3.14% |
| RTW INVESTMENTS, LP | 605,762 | $78,168,000 | 2.95% |
| Consonance Capital Management LP | 356,145 | $45,957,000 | 2.80% |